tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Top Conmed Executive Sells Hundreds of Shares!

Top Conmed Executive Sells Hundreds of Shares!

New insider activity at Conmed ( (CNMD) ) has taken place on August 8, 2025.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Todd W Garner, the Executive Vice President and Chief Financial Officer of Conmed, recently executed a sale of 598 shares of the company’s stock. This transaction amounted to a total value of $31,365.

Recent Updates on CNMD stock

In the last 24 hours, Conmed Corporation (CNMD) has seen significant developments following its Q2 earnings call. The company reported a 3.1% year-over-year increase in sales, with adjusted net income rising by 16.4% to $35.6 million. Despite facing challenges in the orthopedic segment due to supply chain issues and financial pressures from tariffs and foreign exchange, Conmed remains optimistic about its growth outlook. The company’s strategic focus on operational improvements and supply chain stabilization supports this positive sentiment. Analysts have adjusted their price targets, with Piper Sandler lowering its target due to a conservative revenue guide, while acknowledging the company’s top-line turnaround efforts and raised adjusted EPS guidance. Conmed’s management has also narrowed its full-year revenue view and anticipates minimal currency headwinds, maintaining confidence in achieving its updated financial targets.

Spark’s Take on CNMD Stock

According to Spark, TipRanks’ AI Analyst, CNMD is a Outperform.

Conmed’s overall stock score of 74 reflects strong financial performance and a positive earnings call, highlighting solid growth and profitability. The technical analysis suggests moderate momentum with potential resistance, while the valuation and corporate events provide additional support for a positive outlook. The company’s resilience in managing debt and cash flow effectively positions it well for future expansion.

To see Spark’s full report on CNMD stock, click here.

More about Conmed

YTD Price Performance: -21.45%

Average Trading Volume: 438,387

Technical Sentiment Signal: Sell

Current Market Cap: $1.58B

Disclaimer & DisclosureReport an Issue

1